Mitsubishi Tanabe Pharma (4508 JP)

3rd Quarter of FY2019 Business Results Conference Call

Speakers:

• Eizo Tabaru (Member of the Board, Managing Executive Officer, CFO, Mitsubishi Tanabe Pharma Corporation)
• Yasutoshi Kawakami (Executive Officer, Head of Sales & Marketing Division, Mitsubishi Tanabe Pharma Corporation)
• Yoshiaki Takai (Vice President, Head of Corporate Communications Department, Mitsubishi Tanabe Pharma Corporation)
• Motoaki Amano (Vice President, Head of Ikuyaku. Integrated Value Development Division Ikuyaku Strategy & Planning Department, Mitsubishi Tanabe Pharma Corporation)

Analysts:

• Seiji Wakao (Analyst, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.)
• Kazuaki Hashiguchi (Analyst, Daiwa Securities Co. Ltd.)
• Sano (Analyst, JPMorgan Securities Japan Co., Ltd.)
• Shinichiro Muraoka (Analyst, Morgan Stanley MUFG Securities Co., Ltd.)